The immune response to human CMV.

November 27, 2016 at 7:44 pm

Future Virol. 2012 Mar 1;7(3):279-293.

La Rosa C1, Diamond DJ.

Author information

1Division of Translational Vaccine Research, Beckman Research Institute of the City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

Abstract

This review will summarize and interpret recent literature regarding the human CMV immune response, which is among the strongest measured and is the focus of attention for numerous research groups.

CMV is a highly prevalent, globally occurring infection that rarely elicits disease in healthy immunocompetent hosts. The human immune system is unable to clear CMV infection and latency, but mounts a spirited immune-defense targeting multiple immune-evasion genes encoded by this dsDNA β-herpes virus.

Additionally, the magnitude of cellular immune response devoted to CMV may cause premature immune senescence, and the high frequencies of cytolytic T cells may aggravate vascular pathologies.

However, uncontrolled CMV viremia and life-threatening symptoms, which occur readily after immunosuppression and in the immature host, clearly indicate the essential role of immunity in maintaining asymptomatic co-existence with CMV.

Approaches for harnessing the host immune response to CMV are needed to reduce the burden of CMV complications in immunocompromised individuals

PDF

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539762/pdf/nihms429188.pdf

Entry filed under: Infecciones virales, Metodos diagnosticos, REVIEWS, Sepsis, Update. Tags: .

Infección por CMV humano Clinical presentation and risk factors for cytomegalovirus colitis in immunocompetent adult patients.


Calendar

November 2016
M T W T F S S
« Oct   Dec »
 123456
78910111213
14151617181920
21222324252627
282930  

Most Recent Posts


%d bloggers like this: